Superior Group of Companies, Inc. (NASDAQ:SGC) Q3 2023 Earnings Conference Call November 6, 2023 5:00 PM ET Company Participants Michael Benstock - Chief Executive Officer Mike Koempel - Chief Financial Officer Conference Call Participants Kevin Steinke - Barrington Research Jim Sidoti - Sidoti & Company David Marsh - Singular Research Operator Good afternoon, everyone, and welcome to the Superior Group of Companies Third Quarter 2023 Conference Call. With us today are Michael Benstock, Chief Executive Offi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to __________ Commission file number: 001-05869 Exact name of registrant as specified in its charter: SUPERIOR GROUP OF COMPANIES, INC. State or other jurisd ...

Financial Data and Key Metrics Changes - The company generated consolidated second quarter revenues of $129 million, down from $148 million in the same period last year, while adjusted EBITDA increased to $7 million from $5 million in the prior year quarter [3][7][41] - The net income for the second quarter was $1.2 million or $0.08 per diluted share, compared to a net loss of $26.7 million or $1.70 per diluted share in the prior year quarter [8][41] - The updated full-year revenue outlook is now between $550 million to $560 million, down from the previous range of $585 million to $595 million, with earnings per diluted share expected to be between $0.45 to $0.55, down from $0.92 to $0.97 [9] Business Line Data and Key Metrics Changes - Healthcare Apparel revenues increased to $28 million from $26 million in the prior year, reflecting a 7% growth despite soft market conditions [4] - Contact Centers generated second quarter revenues of $23 million, up 6% year-over-year, with adjusted EBITDA of $3.3 million, reflecting a margin of 14% [56] - Branded Products revenues decreased to $80 million from $102 million a year ago, with adjusted EBITDA of $7 million, slightly up from the previous year [73] Market Data and Key Metrics Changes - The company noted that while there are positive signs in the market, there remains uncertainty with some budgets opening up and others not [12][63] - The backlog of orders has increased significantly, indicating potential future revenue growth [12] Company Strategy and Development Direction - The company aims to grow its market share in the Healthcare Apparel segment, targeting the large addressable market of caregivers [55] - There is a focus on improving gross margins and managing expenses in the Branded Products segment to navigate economic uncertainty [73] - The company plans to be more active in M&A next year, contingent on improving leverage ratios [24][102] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the second half of the year, expecting a backend-loaded performance with improved sales trends [9][63] - The company is focused on achieving inventory equilibrium by year-end and is optimistic about the healthcare business improving [27][97] - Management highlighted the importance of reducing debt levels and improving cash flow to position the company for future growth [35][71] Other Important Information - The company reported a slight improvement in its net leverage ratio to 3.7 times trailing 12-month covenant EBITDA, remaining within covenant requirements [59] - The company has made significant progress in operating cash flow, generating $38 million in the first half of the year [71] Q&A Session Summary Question: What has changed regarding the outlook for Branded Products? - Management noted that clients are being more cautious, impacting the outlook for Branded Products [77][78] Question: How close is the company to achieving equilibrium inventory levels? - Management indicated that the next two quarters are critical for reaching inventory equilibrium, with expectations for improvement in the healthcare business [27][97] Question: What is the status of pricing in the Contact Centers segment? - Management confirmed that pricing increases have been implemented to offset higher labor costs, but demand for agents has fluctuated [29][80] Question: How does the company plan to grow market share in Branded Products? - Management emphasized the importance of acquiring salespeople from competitors and potentially pursuing M&A opportunities when leverage ratios improve [90][102] Question: Is the company comfortable with its current covenant compliance? - Management expressed confidence in remaining compliant with covenants and does not anticipate needing further amendments [107]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the d ...

Superior Group of Companies, Inc. (NASDAQ:SGC) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Michael L. Benstock - Chief Executive Officer & Director, Superior Group of Cos., Inc. Michael Koempel - Chief Financial Officer, Superior Group of Cos., Inc. Conference Call Participants Mitra Ramgopal - Sidoti & Co. LLC Kevin Mark Steinke - Barrington Research Associates, Inc. Tim Moore - EF Hutton Group Operator Good afternoon, everyone. Welcome to the Superior Group of Companies’ F ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to __________ Commission file number: 001-05869 Exact name of registrant as specified in its charter: SUPERIOR GROUP OF COMPANIES, INC. State or other ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to _______________ Commission File Number 001-05869 SUPERIOR GROUP OF COMPANIES, INC. (Exact Name of Registrant as Specified in Its Charter) Flori ...

Superior Group of Companies, Inc. (NASDAQ:SGC) Q4 2022 Results Conference Call March 15, 2023 5:00 PM ET Company Participants Michael Benstock - Chief Executive Officer Michael Koempel - Chief Financial Officer Conference Call Participants Kevin Steinke - Barrington Research Tim Moore - EF Hutton Mitra Ramgopal - Sidoti BJ Cook - Singular Research Operator Good afternoon, everyone, and welcome to Superior Group of Companies' Fourth Quarter of 2022 Conference Call. With us today are Michael Benstock, the com ...

1 HEALTHCARE APPAREL Healthcare apparel provider for over 100 years, including retail scrubs brands, industrial laundry scrubs, lab coats, patient apparel and specialty products sold through all CONTACT CENTERS 4 • Taking organic market share in highly fragmented industries ripe for consolidation, with international expansion opportunities INVESTMENT HIGHLIGHTS REVENUE MIX: THEN AND NOW 5 | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------|-----------------------|--------------------------- ...

| --- | --- | --- | --- | |----------------------------------------|-------|-----------------------------------------------------------|-------| | | | | | | | | | | | Investor PRESENTATION November 7, 2022 | | | | | | | Healthcare Apparel \| Branded Products \| Contact Centers | | 1 | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...